CYP2E1 levels are elevated in response to disease (e.g., diabetes), obesity, and nutritional status. As CYP2E1 catalyzes the conversion of low molecular weight environmental toxicants and procarcinogens, as well as therapeutic agents, to reactive toxic and/or carcinogenic products, is active in the metabolism of eicosanoids, and is capable of increasing cellular oxidative stress, there is an increase disease risk associated with elevated CYP2E1 levels and/or xenobiotic exposure. In general, there is an increased incidence of liver disease and cancer in obese individuals, chronic alcoholics, and diabetic individuals. Recent experiments have shown that insulin regulates CYP2E1 mRNA and protein levels in primary cultured hepatocytes in a manner mechanistically identical to that in vivo. Low insulin levels (1 nM) elevate CYP2E1 mRNA and protein levels about 10-fold relative to high insulin concentrations (1 microM). Mechanistic studies implicate the Src kinase, PI 3-kinase, Akt kinase/Protein kinase B, p70 S6 kinase signaling cascade in regulation of CYP2E1 expression and polyribosomal distribution, and mRNA EMSA studies incriminate cytoplasmic storage and translation in CYP2E1 mRNA stabilization. The hypothesis of this research is that the Src kinase, PI 3-kinase, Akt kinase/Protein kinase B, p70 S6 kinase signaling pathway regulates CYP2E1 gene expression via post-transcriptional events affecting cytoplasmic mRNA storage and turnover. Thus, the specific objectives of this research are: 1) To examine the effects of Src kinase, PI 3-kinase, Akt/Protein kinase B and p70 S6 kinase inhibitors and PP1, PP2A, and PP2B phosphatase inhibitors on CYP2E1 transcription rates and mRNA turnover (stability) in the presence and absence of insulin; 2) To definitively assess with dominant negative Src kinase, PI 3-kinase, and Akt/Protein kinase B constructs the role of Src kinase, PI 3-kinase, and Akt/Protein kinase B on CYP2E1 mRNA levels in primary cultured hepatocytes; 3) To assess the role of kinase signaling in protein binding to CYP2E1 mRNA constructs; 4) To examine whether altered kinase, phosphatase activity affects cytoplasmic CYP2E1 mRNA storage. The experiments will provide a mechanistic understanding of the seminal observation that Src kinase, PI 3-kinase, Akt kinase/Protein kinase B, p70 S6 kinase signaling regulates CYP2E1 expression. The results of this research will provide valuable information on how hormonal status affects the elevation of gene products that increase the risk of disease associated with either xenobiotic exposure or with the conversion of endogenous fatty acids, eicosanoids or steroids to physiologically active modulators of cell and organ function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES003656-14
Application #
6382069
Study Section
Alcohol and Toxicology Subcommittee 4 (ALTX)
Program Officer
Mcclure, Michael
Project Start
1988-04-01
Project End
2005-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
14
Fiscal Year
2001
Total Cost
$298,000
Indirect Cost
Name
Wayne State University
Department
Type
Organized Research Units
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Shukla, Upasana; Tumma, Nithin; Gratsch, Theresa et al. (2013) Insights into insulin-mediated regulation of CYP2E1: miR-132/-212 targeting of CYP2E1 and role of phosphatidylinositol 3-kinase, Akt (protein kinase B), mammalian target of rapamycin signaling in regulating miR-132/-212 and miR-122/-181a expression in pri Drug Metab Dispos 41:1769-77
Hudder, Alice; Novak, Raymond F (2008) miRNAs: effectors of environmental influences on gene expression and disease. Toxicol Sci 103:228-40
Kim, Sang K; Novak, Raymond F (2007) The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol Ther 113:88-120
Kim, Sang K; Abdelmegeed, Mohamed A; Novak, Raymond F (2006) Identification of the insulin signaling cascade in the regulation of alpha-class glutathione S-transferase expression in primary cultured rat hepatocytes. J Pharmacol Exp Ther 316:1255-61
Kim, Sang K; Abdelmegeed, Mohamed A; Novak, Raymond F (2006) The mitogen-activated protein kinase kinase (mek) inhibitor PD98059 elevates primary cultured rat hepatocyte glutathione levels independent of inhibiting mek. Drug Metab Dispos 34:683-9
Abdelmegeed, Mohamed A; Carruthers, Nicholas J; Woodcroft, Kimberley J et al. (2005) Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes. J Pharmacol Exp Ther 315:203-13
Kim, Sang K; Woodcroft, Kimberley J; Oh, Soo Jin et al. (2005) Role of mechanical and redox stress in activation of mitogen-activated protein kinases in primary cultured rat hepatocytes. Biochem Pharmacol 70:1785-95
Abdelmegeed, Mohamed A; Kim, Sang K; Woodcroft, Kimberley J et al. (2004) Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress. J Pharmacol Exp Ther 310:728-36
Kim, Sang K; Woodcroft, Kimberley J; Khodadadeh, Sarah S et al. (2004) Insulin signaling regulates gamma-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes. J Pharmacol Exp Ther 311:99-108
Kim, Sang K; Woodcroft, Kimberley J; Kim, Sang G et al. (2003) Insulin and glucagon signaling in regulation of microsomal epoxide hydrolase expression in primary cultured rat hepatocytes. Drug Metab Dispos 31:1260-8

Showing the most recent 10 out of 43 publications